These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 10852265

  • 1. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy.
    Ordi-Ros J, Cortés F, Cucurull E, Mauri M, Buján S, Vilardell M.
    J Rheumatol; 2000 Jun; 27(6):1429-33. PubMed ID: 10852265
    [Abstract] [Full Text] [Related]

  • 2. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR.
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [Abstract] [Full Text] [Related]

  • 3. [Thalidomide therapy for discoid lupus erythematosus].
    Lyakhovisky A, Baum S, Shpiro D, Salomon M, Trau H.
    Harefuah; 2006 Jul; 145(7):489-92, 551. PubMed ID: 16900736
    [Abstract] [Full Text] [Related]

  • 4. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
    Cortés-Hernández J, Torres-Salido M, Castro-Marrero J, Vilardell-Tarres M, Ordi-Ros J.
    Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
    [Abstract] [Full Text] [Related]

  • 5. Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients.
    Hasper MF.
    Arch Dermatol; 1983 Oct; 119(10):812-5. PubMed ID: 6614949
    [Abstract] [Full Text] [Related]

  • 6. Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus.
    Thomson KF, Goodfield MJ.
    J Dermatolog Treat; 2001 Sep; 12(3):145-7. PubMed ID: 12243705
    [Abstract] [Full Text] [Related]

  • 7. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP.
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [Abstract] [Full Text] [Related]

  • 8. Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China.
    Wang D, Chen H, Wang S, Zou Y, Li J, Pan J, Wang X, Ren T, Zhang Y, Chen Z, Feng X, Sun L.
    Clin Rheumatol; 2016 Jun; 35(6):1521-7. PubMed ID: 27097914
    [Abstract] [Full Text] [Related]

  • 9. [Thalidomide and thrombosis].
    Flageul B, Wallach D, Cavelier-Balloy B, Bachelez H, Carsuzaa F, Dubertret L.
    Ann Dermatol Venereol; 2000 Feb; 127(2):171-4. PubMed ID: 10739975
    [Abstract] [Full Text] [Related]

  • 10. Transient secondary amenorrhea in women treated by thalidomide.
    Frances C, El Khoury S, Gompel A, Bécherel PA, Chosidow O, Piette JC.
    Eur J Dermatol; 2002 Feb; 12(1):63-5. PubMed ID: 11809598
    [Abstract] [Full Text] [Related]

  • 11. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.
    Coelho A, Souto MI, Cardoso CR, Salgado DR, Schmal TR, Waddington Cruz M, de Souza Papi JA.
    Lupus; 2005 Feb; 14(6):434-9. PubMed ID: 16038106
    [Abstract] [Full Text] [Related]

  • 12. [Low-dose thalidomide in refractory and relapsing multiple myeloma].
    Radocha J, Maisnar V.
    Vnitr Lek; 2007 Feb; 53(2):129-34. PubMed ID: 17419173
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
    Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre MS, Broly F, Piette F, Bergoend H.
    Ann Dermatol Venereol; 1997 Feb; 124(2):151-6. PubMed ID: 9740825
    [Abstract] [Full Text] [Related]

  • 14. [Sarcoidosis: thalidomide treatment in ten patients].
    Estines O, Revuz J, Wolkenstein P, Bressieux JM, Roujeau JC, Cosnes A.
    Ann Dermatol Venereol; 2001 May; 128(5):611-3. PubMed ID: 11427794
    [Abstract] [Full Text] [Related]

  • 15. A case series of 48 patients treated with thalidomide.
    Doherty SD, Hsu S.
    J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
    [Abstract] [Full Text] [Related]

  • 16. [Thalidomide therapy of cutaneous lupus erythematosus].
    Bohmeyer J, Achenbach A, Westenberger M, Stadler R.
    Hautarzt; 2002 Nov; 53(11):744-8. PubMed ID: 12402138
    [Abstract] [Full Text] [Related]

  • 17. Treatment of cutaneous sarcoidosis with thalidomide.
    Nguyen YT, Dupuy A, Cordoliani F, Vignon-Pennamen MD, Lebbé C, Morel P, Rybojad M.
    J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
    [Abstract] [Full Text] [Related]

  • 18. Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation.
    Cummins DL, Gaspari AA.
    Br J Dermatol; 2004 Aug; 151(2):458-64. PubMed ID: 15327555
    [Abstract] [Full Text] [Related]

  • 19. Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.
    Raptopoulou A, Linardakis C, Sidiropoulos P, Kritikos HD, Boumpas DT.
    Lupus; 2010 May; 19(6):744-7. PubMed ID: 20179172
    [Abstract] [Full Text] [Related]

  • 20. Prurigo nodularis of Hyde treated with low-dose thalidomide.
    Orlando A, Renna S, Cottone M.
    Eur Rev Med Pharmacol Sci; 2009 May; 13(2):141-5. PubMed ID: 19499850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.